Why is Amgen Inc. (AMGN) down today (-1.37%)?
Educational Guide:Analyst Ratings & Target Valuation Guide →
Diplyzer AI Agent• AMGN AI Analysis
AMGN
NASDAQHealthcareAmgen Inc.
$407.44
-5.64 (-1.37%)• Rating: B+
Day Range
400.06 - 411.84
52W Range
288.00 - 447.03
Market Cap
$219.90B
Volume
2.37M
Amgen Inc. (AMGN) completed a Closing Marubozu pattern on 25 Sept 2026 trading at $407.44 (-1.37% today, +3.6% over 1M). Overall financial health rating sits at B+.
Key AI Agent Insights
- Financial Health: Amgen Inc. reported a P/E ratio of 20.6 and ROE of 20.3% in its quarterly Q2 financial report dated 30 Jun 2026.(Learn about Financial Ratios & Health →)
- Analyst Consensus: Wall Street analysts maintain a Buy consensus rating on Amgen Inc. Most recently, Cantor Fitzgerald maintained its rating to Neutral on 8 Oct 2026.(Learn about Analyst Ratings →)
- Insider Activity: Corporate insiders recorded 5 purchases and 3 sales in AMGN, with the latest Form 4 filing executed on 1 Sept 2026. In Congress, Rep. David Taylor reported a purchase in AMGN ($1,001 - $15,000) executed on 22 Sept 2026 (disclosed 2 Oct 2026).(Learn about Insider Trading & Disclosures →)
- News Sentiment: Financial news coverage for AMGN skews bullish with 75% positive sentiment across 10 tracked articles.(Learn about News & Market Sentiment →)
- Technical Pattern Setup: Amgen Inc. chart analysis shows a Closing Marubozu pattern detected on 25 Sept 2026, establishing a Neutral technical bias.(Learn about Technical Chart Patterns →)